Artificial heart to give new hope to heart failure patients
A revolutionary, implantable mechanical device to be tested at The Alfred is set to provide new hope to patients with debilitating heart failure.
Visitor information – Everything you need to know about visiting our sites.
Our Cardiothoracic Unit performs a full range of adult cardiac and thoracic surgery including minimally invasive valve operations, off-pump surgery and aortic surgery, as well as providing statewide heart and lung transplant services.
The Alfred's transplant program is supported by the mechanical assist device program, which involves 20-30 Ventricular Assist Device (VAD) implants per year as well as supporting a busy extracorporeal membrane oxygenation (ECMO) program.
Our research is focussed on:
We support a busy trauma service at The Alfred and continue rib fixation research for severe chest wall injuries.
Find out more about our Cardiothoracic Surgery service.
See Hoe LE, Wildi K, Obonyo NG, Bartnikowski N, McDonald C, Sato K, Heinsar S, Engkilde-Pedersen S, Diab S, Passmore MR, Wells MA, Boon AC, Esguerra A, Platts DG, James L, Bouquet M, Hyslop K, Shuker T, Ainola C, Colombo SM, Wilson ES, Millar JE, Malfertheiner MV, Reid JD, O'Neill H, Livingstone S, Abbate G, Sato N, He T, von Bahr V, Rozencwajg S, Byrne L, Pimenta LP, Marshall L, Nair L, Tung JP, Chan J, Haqqani H, Molenaar P, Li Bassi G, Suen JY, McGiffin DC, Fraser JF
(2021), Intensive Care Medicine Experimental, 9(1), 60
Bhaskaran P, Ou R, Marasco S, Perera S, Brookes J, Rosenfeldt F
(2021), Transplantation, 105(7), 1510-15
Prins JTH, Van Lieshout EMM, Ali-Osman F, Bauman ZM, Caragounis EC, Choi J, Christie DB 3rd, Cole PA, DeVoe WB, Doben AR, Eriksson EA, Forrester JD, Fraser DR, Gontarz B, Hardman C, Hyatt DG, Kaye AJ, Ko HJ, Leasia KN, Leon S, Marasco SF, McNickle AG, Nowack T, Ogunleye TD, Priya P, Richman AP, Schlanser V, Semon GR, Su YH, Verhofstad MHJ, Whitis J, Pieracci FM, Wijffels MME
(2021), J TRAUMA ACUTE CARE, 90(3), 492-500
A revolutionary, implantable mechanical device to be tested at The Alfred is set to provide new hope to patients with debilitating heart failure.
Heart patients of the future are set to benefit from a new partnership which will bring together the combined strengths of three leading institutions in cardiovascular research and patient care.
When 43-year-old Melbourne dad Mark Wohlers suffered a cardiac arrest last year, it was the swift emergency response and an Australian-first clinical trial that gave him a second chance at life.